Borviz 2 Injection 1 is designed to manage multiple myeloma, a cancer of plasma cells in the bone marrow. This medicine is part of a group known as proteasome inhibitors.
In addition to this primary use, this injection is also used to manage mantle cell lymphoma, a type of non-Hodgkin's lymphoma affecting the lymph nodes in adults who have undergone at least one previous therapy.
This medicine should be administered as directed by your doctor in a healthcare setting. It's vital to inform your doctor about any pre-existing conditions or ongoing medications before starting this medicine. If you notice any side effects while on this medicine, notify your doctor immediately. Continue with the medicine for the duration prescribed by your doctor for optimal results.